Which stage you are in — and why it matters more than the diagnosis itself

If you have been told you have frozen shoulder, the most useful question is not what it is but which stage you are in — because the answer changes what you should be doing today.

The condition moves through three overlapping phases, each with a distinct dominant symptom. In the Freezing stage (typically two to nine months), pain is the overriding problem. It is often severe at night, wakes you from sleep, and is aggravated by lying on the affected side. Reaching overhead or behind your back becomes increasingly difficult, but stiffness is still developing rather than fixed.

In the Frozen stage (four to twelve months), pain may partially ease — a change that can feel deceptively like improvement — while stiffness reaches its peak. Everyday tasks such as dressing, reaching into a back seat, or fastening a seatbelt become genuinely difficult. This is the phase in which mobility, not pain control, becomes the priority.

The Thawing stage (twelve to forty-two months) brings gradual return of movement. Total recovery across all three stages typically spans eighteen months to three years.

The condition is self-limiting: most patients reach near-full recovery eventually, even without treatment. Self-limiting does not mean untreatable, however — intervention can meaningfully shorten the period of pain and disability, even if it does not alter the underlying biological process.

Stage boundaries are imprecise, and individual variation in duration is high. That imprecision matters, because patients who cannot confidently place themselves in a stage are poorly equipped to judge whether their current management is appropriate — or whether it is time to escalate.

How each stage shifts the treatment priority

Treatment that is well matched to one stage can feel actively counterproductive in another — a point that is easy to miss when the same diagnosis appears on every letter.

Freezing stage: prioritise pain control

With pain as the dominant symptom, the goal at this stage is to reduce inflammation and make the shoulder tolerable. Over-the-counter analgesia and NSAIDs form the first line. Corticosteroid injections — intra-articular steroid delivered by a specialist — are recommended in clinical guidelines for this phase and can provide meaningful, if temporary, relief. They do not alter the natural course of the condition, but they matter a great deal to sleep and daily function. Aggressive stretching at this point is counterproductive: forcing range of movement into an actively inflamed joint worsens pain without accelerating recovery.

Frozen stage: shift to mobility

Once pain has partially settled and stiffness becomes the limiting factor, the priority shifts to restoring movement. Physiotherapy and manual therapy become central here. A 2025 literature review confirmed that early manual therapy combined with structured exercise yields the best functional outcomes — underlining why reaching this intervention promptly matters. Hydrodilatation (an injection of fluid used to stretch the joint capsule) is a further option for this phase, though most trial evidence does not separate results by stage, so its optimal timing window remains uncertain.

Thawing stage: progressive rehabilitation

As movement begins to return naturally, the aim is to build on it through graded exercise. Passive approaches and repeat injections add little value at this point; consistent, progressive rehabilitation drives recovery.

A common and frustrating mismatch occurs when patients receive mobility-focused physiotherapy while they are still firmly in the Freezing stage — when pain, not stiffness, is the true obstacle.

How the NHS pathway is structured — and where the timing gap appears

The NHS pathway is built around a logical sequence: start with the least invasive option, move to the next only if it does not work. In practice, that means exhausting community-based management — analgesia, a corticosteroid injection if needed, and GP-referred physiotherapy lasting at least six weeks — before a hospital referral is considered.

At hospital level, three main options are available. Physiotherapy delivered in a secondary-care setting focuses on structured rehabilitation. Manipulation under anaesthesia (MUA) is a procedure in which the shoulder is moved through its range of motion whilst the patient is under general anaesthetic, breaking down restrictive tissue. Arthroscopic capsular release (ACR) is a surgical procedure in which the tight joint capsule is divided under direct vision. A large head-to-head comparison published by the NIHR in 2021 found all three effective at one year. MUA is the most cost-effective; physiotherapy is the fastest to access but carries a higher rate of re-referral for further treatment; ACR carries the greatest risk and cost.

The structural gap emerges from the sequencing itself. Completing community management before accessing hospital-level care can consume several months — months that, for many patients, fall squarely within the Freezing or Frozen stage. This is precisely the therapeutic window when specialist input carries the most weight. As a population-level triage system the pathway is rational; it can become a poor fit for the individual patient whose condition continues to advance whilst the queue moves slowly.

One further timing difference applies at the hospital stage: MUA requires an anaesthetic list, which typically means a longer wait than outpatient physiotherapy — a practical distinction worth understanding when weighing the available options.

When private assessment is genuinely worth considering

Two scenarios make private assessment genuinely useful rather than merely convenient.

The first is diagnostic uncertainty. If you cannot confidently place yourself in the Freezing or Frozen stage — and many patients cannot, because the stages overlap — you may not know whether your priority today is pain control or mobility work. A single specialist assessment resolves that directly. Specialist ultrasound can measure coracohumeral ligament thickness (the validated cut-off is ≥2.2 mm, with 77% sensitivity and 91.8% specificity) and axillary recess depth (≥4 mm) to confirm stage objectively at the same appointment, giving the clinician an evidence-based foundation for a treatment plan before you leave.

The second is symptoms that have passed the point of watchful waiting. Night pain that breaks sleep and a noticeable loss of overhead movement are the clinical signals that delay has become the wrong strategy. If these are present and an NHS hospital-level appointment is still several months away, the therapeutic window for the most effective interventions may be narrowing in the interim.

Private assessment — available at MSK Doctors sites including Sleaford and Grantham — offers same-day imaging and same-session specialist review without a GP referral.

On cost: full private shoulder arthroscopy runs £3,000–£6,500. However, full private surgery is not the only alternative to an NHS queue. A hybrid pathway is documented and realistic: use a private consultation to obtain a confirmed stage and a clear treatment plan, then return to the NHS for funded treatment. Many patients are unaware this option exists.

There is no large trial directly comparing early private assessment against standard NHS community management for overall recovery duration. What the available evidence does support, however, is that treatment matched to the correct stage shortens disability — the practical question is therefore about timing access to that matching, not whether it matters.

What a specialist assessment for frozen shoulder actually involves

A specialist assessment follows a consistent sequence: clinical history, physical examination, imaging, and a stage-specific treatment plan.

The history establishes symptom duration, the presence and severity of night pain, and whether there was an identifiable trigger — factors that together help place the presentation within the three-stage framework described earlier.

Physical examination tests passive and active range of motion in all planes. Restriction in external rotation is the hallmark finding; the pattern of loss across planes also helps distinguish frozen shoulder from rotator cuff pathology, which can produce a superficially similar clinical picture.

Ultrasound is the first-line imaging tool for staged confirmation, measuring coracohumeral ligament thickness and axillary recess depth against the validated cut-offs noted above. MRI adds value when the differential remains uncertain — rotator cuff pathology and adhesive capsulitis can coexist, and an unrecognised full-thickness cuff tear changes the treatment approach substantially.

In some settings, objective motion-capture assessment — including UKCA-registered markerless systems such as MAI Motion® — can provide quantified biomechanical data on shoulder restriction where tracking change over time is clinically useful.

The output of all this is a stage-confirmed diagnosis and a time-phased plan: which intervention, in what order, and why now rather than later. Private specialist clinics in the UK typically accept direct self-referral without a GP letter, which can bring this assessment forward by several weeks compared with the standard community referral pathway.

What recovery from frozen shoulder realistically looks like

Recovery from frozen shoulder is measured more usefully in what the shoulder can do than in degrees of motion recorded at a clinic appointment. The ability to reach a top shelf, fasten a bra strap, or sleep on the affected side without waking tells a patient more about genuine progress than a goniometer reading of 110 versus 120 degrees of abduction.

Progress is not linear. Pain typically improves before mobility, and a plateau in stiffness during the Frozen stage — sometimes lasting several months — is a normal feature of the natural course, not evidence that treatment has stopped working. Individual variation in stage duration is high; the overall trajectory runs anywhere from 18 months to 3 years, and published ranges reflect populations rather than predictions for any individual.

Signs that warrant re-assessment rather than continued waiting:

• No meaningful improvement in pain after three months of appropriate management
• Persistent severe night pain that continues to disrupt sleep
• New neurological symptoms — numbness, pins and needles, or unexplained weakness in the arm or hand

Return to full activity is criteria-based rather than time-based: pain-free range of movement, symmetry of strength compared with the other side, and confidence in task-specific loading are the practical thresholds — not a date on the calendar.

For patients who want specialist input on where they sit in this trajectory without waiting for a GP referral, MSK Doctors accepts self-referrals at its Sleaford and Grantham sites. A functioning shoulder — capable, pain-free, and reliably available for daily demands — is the outcome that every stage of assessment and treatment is ultimately working towards.

1. [1] Shoulder adhesive capsulitis: Clinical aspects and practical algorithmic approach. (2025). https://doi.org/10.1097/BCO.0000000000001303 https://doi.org/10.1097/BCO.0000000000001303
2. [2] Clinical Practice Guidelines for Diagnosis and Non-Surgical Treatment of Primary Frozen Shoulder. (2025). https://doi.org/10.5535/arm.250057 https://doi.org/10.5535/arm.250057
3. [3] Effectiveness of Manual Therapy among Patients with Adhesive Capsulitis: A Literature Review. (2025). https://doi.org/10.7860/jcdr/2025/80478.21729 https://doi.org/10.7860/jcdr/2025/80478.21729
4. [4] Frozen shoulder – NHS. https://www.nhs.uk/conditions/frozen-shoulder/ https://www.nhs.uk/conditions/frozen-shoulder/
5. [5] Effects of Hydrodilatation at Different Volumes on Adhesive Capsulitis in Phases 1 and 2. (2025). https://doi.org/10.3390/clinpract15080141 https://doi.org/10.3390/clinpract15080141